Methods of treatment with antagonists of MU-1
US7189400B2 · kind B2 · utility
8Cited by
25References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 4, 2001 |
| Grant date | Mar 13, 2007 |
| Priority date | — |
| Expiry date | Oct 4, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is a method of suppressing an immune response in a subject by administering an antagonist of a MU-1 hematopoietin receptor superfamily chain protein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.